Original language | English |
---|---|
Pages (from-to) | 1377-1384 |
Number of pages | 8 |
Journal | Experimental Hematology |
Volume | 34 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2006 |
Austrian Fields of Science 2012
- 3012 Pharmacy, Pharmacology, Toxicology
Keywords
- NF-KAPPA-B
- CHEMOPREVENTIVE AGENT RESVERATROL
- SK-MEL-28 MELANOMA-CELLS
- NITRIC-OXIDE SYNTHASE
- S-PHASE ARREST
- COLORECTAL-CANCER
- BREAST-CANCER
- RIBONUCLEOTIDE REDUCTASE
- ANTIINFLAMMATORY DRUGS
- POTENT INDUCER
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Experimental Hematology, Vol. 34, No. 10, 10.2006, p. 1377-1384.
Publications: Contribution to journal › Article › Peer Reviewed
TY - JOUR
T1 - Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells
AU - Horvath, Zsuzsanna
AU - Murias, Marek
AU - Saiko, Philipp
AU - Erker, Thomas
AU - Handler, Norbert
AU - Jäger, Walter
AU - Grusch, Michael
AU - Fritzer-Szekeres, Monika
AU - Krupitza, Georg
AU - Szekeres, Thomas
N1 - Coden: EXHEB Affiliations: Clinical Institute of Medical, Chemical Laboratory Diagnostics, General Hospital of Vienna, Vienna, Austria; Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria; Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria Source-File: MedPharmChemScopus_iso.csv Import aus Scopus: 2-s2.0-33748569521DOI: 10.1016/j.exphem.2006.05.018 Coden: EXHEB Affiliations: Clinical Institute of Medical, Chemical Laboratory Diagnostics, General Hospital of Vienna, Vienna, Austria; Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria; Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria Source-File: MedPharmChemScopus_iso.csv Import aus Scopus: 2-s2.0-33748569521DOI: 10.1016/j.exphem.2006.05.018 Coden: EXHEB Affiliations: Clinical Institute of Medical, Chemical Laboratory Diagnostics, General Hospital of Vienna, Vienna, Austria; Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria; Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria Source-File: MedPharmChemScopus_iso.csv Import aus Scopus: 2-s2.0-33748569521DOI: 10.1016/j.exphem.2006.05.018 Coden: EXHEB Affiliations: Clinical Institute of Medical, Chemical Laboratory Diagnostics, General Hospital of Vienna, Vienna, Austria; Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria; Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria Source-File: MedPharmChemScopus_iso.csv Import aus Scopus: 2-s2.0-33748569521DOI: 10.1016/j.exphem.2006.05.018 Coden: EXHEB Affiliations: Clinical Institute of Medical, Chemical Laboratory Diagnostics, General Hospital of Vienna, Vienna, Austria; Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria; Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria Source-File: MedPharmChemScopus_iso.csv Import aus Scopus: 2-s2.0-33748569521 Importdatum: 22.11.2006 17:16:21 09.08.2007: Datenanforderung 1815 (Import Sachbearbeiter) 09.02.2010: Datenanforderung UNIVIS-DATEN-DAT.RA-2 (Import Sachbearbeiter)
PY - 2006/10
Y1 - 2006/10
KW - NF-KAPPA-B
KW - CHEMOPREVENTIVE AGENT RESVERATROL
KW - SK-MEL-28 MELANOMA-CELLS
KW - NITRIC-OXIDE SYNTHASE
KW - S-PHASE ARREST
KW - COLORECTAL-CANCER
KW - BREAST-CANCER
KW - RIBONUCLEOTIDE REDUCTASE
KW - ANTIINFLAMMATORY DRUGS
KW - POTENT INDUCER
U2 - 10.1016/j.exphem.2006.05.018
DO - 10.1016/j.exphem.2006.05.018
M3 - Article
SN - 0301-472X
VL - 34
SP - 1377
EP - 1384
JO - Experimental Hematology
JF - Experimental Hematology
IS - 10
ER -